Finlanda - finlandeză - Fimea (Suomen lääkevirasto)

uab norameda - daptomycin - injektio-/infuusiokuiva-aine liuosta varten - 500 mg - daptomysiini

Finlanda - finlandeză - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - daptomycin - injektio-/infuusiokuiva-aine liuosta varten - 350 mg - daptomysiini

Finlanda - finlandeză - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - daptomycin - injektio-/infuusiokuiva-aine liuosta varten - 500 mg - daptomysiini

Uniunea Europeană - finlandeză - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - tuberkuloosi, monilääkeresistenssi - mykobakteerilÄÄkkeet - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.

Finlanda - finlandeză - Fimea (Suomen lääkevirasto)

be pharma b.v. - daptomycin - injektio/infuusiokuiva-aine, liuosta varten - 350 mg - daptomysiini

Finlanda - finlandeză - Fimea (Suomen lääkevirasto)

be pharma b.v. - daptomycin - injektio/infuusiokuiva-aine, liuosta varten - 500 mg - daptomysiini

Uniunea Europeană - finlandeză - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastiset aineet - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Uniunea Europeană - finlandeză - EMA (European Medicines Agency)

janssen-cilag international n.v. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - zytiga on merkitty prednisoni tai prednisoloni:metastasoituneen kastraation kastraatioresistentin eturauhassyövän aikuiset miehet, jotka ovat oireettomia tai lievästi oireileva jälkeen epäonnistuminen androgeenideprivaatiohoito joille kemoterapiaa ei ole vielä kliinisesti indicatedthe metastasoituneen kastraation kestävä eturauhassyövän hoitoon aikuisilla miehillä, joiden tauti on edennyt, tai kun docetaxel perustuu solunsalpaajahoito.

Uniunea Europeană - finlandeză - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Uniunea Europeană - finlandeză - EMA (European Medicines Agency)

mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.